Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sotera Health (SHC) Cash from Operations: 2020-2025

Historic Cash from Operations for Sotera Health (SHC) over the last 6 years, with Sep 2025 value amounting to $71.2 million.

  • Sotera Health's Cash from Operations fell 26.99% to $71.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $239.8 million, marking a year-over-year decrease of 14.83%. This contributed to the annual value of $224.2 million for FY2024, which is 251.74% up from last year.
  • Latest data reveals that Sotera Health reported Cash from Operations of $71.2 million as of Q3 2025, which was up 23.93% from $57.4 million recorded in Q2 2025.
  • Sotera Health's 5-year Cash from Operations high stood at $113.1 million for Q4 2023, and its period low was -$336.6 million during Q2 2023.
  • Over the past 3 years, Sotera Health's median Cash from Operations value was $55.7 million (recorded in 2024), while the average stood at $23.7 million.
  • Its Cash from Operations has fluctuated over the past 5 years, first soared by 886.98% in 2021, then slumped by 677.42% in 2023.
  • Quarterly analysis of 5 years shows Sotera Health's Cash from Operations stood at $66.4 million in 2021, then surged by 53.62% to $101.9 million in 2022, then increased by 10.99% to $113.1 million in 2023, then tumbled by 50.75% to $55.7 million in 2024, then declined by 26.99% to $71.2 million in 2025.
  • Its last three reported values are $71.2 million in Q3 2025, $57.4 million for Q2 2025, and $55.5 million during Q1 2025.